Covid – 19: Cuidados farmacêuticos durante a pandemia

Article Sidebar

PDF
Publicado: Jan 1, 2020
DOI: https://doi.org/10.25061/2527-2675/ReBraM/2020.v23i1.973
Palavras-chave:
pandemia, coronavírus, COVID-19, profissionais da saúde, cuidados farmacêuticos

Main Article Content

Túlio di Orlando Cagnazzo
Universidade de Araraquara - UNIARA
Bruna Galdorfini Chiari-Andréo
Docente da Universidade de Araraquara - UNIARA nos cursos de graduação em Farmácia, Estética e Cosmética e Biomedicina, pós-graduação presencial em Estética Facial a Corporal, além de cursos de pós-graduação a distância (EAD) na área de Cosmetologia e Estética.

Resumo

O novo Coronavírus, causador da doença respiratória COVID-19, já infectou mais de 5 milhões de pessoas em 181 países, causando diversos problemas econômicos e sociais no mundo. Ainda não há tratamento ou vacina eficaz, então os esforços para redução da transmissão são foco do sistema de saúde. Em epidemias de doenças contagiosas, profissionais de saúde correm um risco maior do que a população em geral de se contaminar. Nesse contexto, o farmacêutico exerce papel importante no controle da transmissão da doença e na atenção às necessidades da comunidade durante a crise, disseminando informações sobre a doença, além de monitorar reações advindas do uso de medicamentos. Sendo assim, o trabalho proposto visa detalhar a função do farmacêutico na linha de frente ao combate a COVID-19 e esclarecer seu envolvimento no controle e prevenção da pandemia. Para alcançar este objetivo, bases de dados, como Google Acadêmico, Scielo, Science Direct e PubMed, foram utilizadas na busca de evidências sobre o novo Coronavírus, bem como da atuação dos farmacêuticos neste cuidado à população. Os unitermos utilizados foram: Coronavírus, COVID-19, SARS-CoV-2, Pharmaceutical care, Healthcare workers. Desta forma, obteve-se informações de publicações entre os anos 2003 a 2020 para esta revisão. Com este estudo podemos inferir que farmácias se tornaram o primeiro contato de muitos indivíduos contaminados com o atendimento de saúde especializado. Com isto, este profissional torna-se importante no controle do medo coletivo e da falta de informação, que devem ser combatidos através de informações confiáveis, contribuindo para redução da sobrecarga sobre o sistema de saúde.

Downloads

Não há dados estatísticos.

Article Details

Como Citar
Cagnazzo, T. di O., & Chiari-Andréo, B. G. (2020). Covid – 19: Cuidados farmacêuticos durante a pandemia. Revista Brasileira Multidisciplinar, 23(1), 161-178. https://doi.org/10.25061/2527-2675/ReBraM/2020.v23i1.973
Edição
v. 23 n. 1 (2020): Janeiro-Abril
Seção
Artigo de Divulgação
  • O(s) autor(es) autoriza(m) a publicação do artigo na revista;


• O(s) autor(es) garante(m) que a contribuição é original e inédita e que não está em processo de avaliação em outra(s) revista(s);


• A revista não se responsabiliza pelas opiniões, ideias e conceitos emitidos nos textos, por serem de inteira responsabilidade de seu(s) autor(es);


• É reservado aos editores o direito de proceder ajustes textuais e de adequação do artigo às normas da publicação.

 

Os conteúdos da Revista Brasileira Multidisciplinar – ReBraM estão licenciados sob uma Licença Creative Commons 4.0 by. 

Qualquer usuário tem direito de:

  • Compartilhar — copiar, baixar, imprimir ou redistribuir o material em qualquer suporte ou formato.
  • Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.

 De acordo com os seguintes termos:

  • Atribuição — Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de maneira alguma que sugira ao licenciante a apoiar você ou o seu uso.
  • Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.

Autores concedem à ReBraM os direitos autorais, com o trabalho simultaneamente licenciado sob a Licença Creative Commons 4.0 by. , que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.

Crossref
Scopus
Google Scholar
Europe PMC

Referências

ADAMS, J. G.; WALLS, R. M. Supporting the Health Care Workforce During the COVID-19 Global Epidemic. JAMA, v. 323, n. 15, p. 1439, 12 mar. 2020.

ADHIKARI, S. P. et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infectious Diseases of Poverty, v. 9, n. 1, p. 1–12, 2020.

AGOMO, C. O. The role of community pharmacists in public health: A scoping review of the literature. Journal of Pharmaceutical Health Services Research, v. 3, n. 1, p. 25–33, 2012.

AHN, D. G. et al. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). Journal of Microbiology and Biotechnology, v. 30, n. 3, p. 313–324, 2020.

BACKER, J. A.; KLINKENBERG, D.; WALLINGA, J. Incubation period of 2019 novel coronavirus (2019- nCoV) infections among travellers from Wuhan, China, 20 28 January 2020. Eurosurveillance, v. 25, n. 5, p. 1–6, 2020.

BAKER, M. G.; PECKHAM, T. K.; SEIXAS, N. S. Estimating the burden of United States workers exposed to infection or disease: A key factor in containing risk of COVID-19 infection. Plos One, v. 15, n. 4, p. e0232452, 2020.

BHAGAVATHULA, A. et al. Novel Coronavirus (COVID-19) Knowledge and Perceptions: A Survey of Healthcare Workers (Preprint). JMIR Public Health and Surveillance, v. 6, p. 1–9, 2020.

BUKHARI, N. et al. Pharmacists at the frontline beating the COVID-19 pandemic. Journal of Pharmaceutical Policy and Practice, v. 13, n. 1, p. 1–4, 2020.

BULUT, C.; KATO, Y. Epidemiology of covid-19. Turkish Journal of Medical Sciences, v. 50, n. SI-1, p. 563–570, 2020.

CENTERS FOR DISEASE CONTROL AND PREVENTION. Disponível em: https://www.cdc.gov/coronavirus/2019-ncov/index.html. Acesso em 21 de maio de 2020.

CHAN-YEUNG, M. Severe acute respiratory syndrome (SARS) and healthcare workers. International Journal of Occupational and Environmental Health, v. 10, n. 4, p. 421–427, 2004.

CHIH CHENG, L. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, v. 55, n. January, p. 1–9, 2020.

CHIN, T. W. F. et al. Severe acute respiratory syndrome (SARS): The pharmacist’s role. Pharmacotherapy, v. 24, n. 6, p. 705-712, jun. 2004.

COWLING, B. J.; LEUNG, G. M. Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, v. 25, n. 6, p. 1–5, 13 fev. 2020.

DASHRAATH, P. et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. American Journal of Obstetrics and Gynecology, v. 2019, 2020.

DE WIT, E. et al. SARS and MERS: Recent insights into emerging coronaviruses. Nature Reviews Microbiology, v. 14, n. 8, p. 523–534, 2016.

DI GENNARO, F. et al. Coronavirus diseases (COVID-19) current status and future perspectives: A narrative review. International Journal of Environmental Research and Public Health, v. 17, n. 8, 2020.

DOLOVICH, L. et al. Pharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people’s lives in the context of health care trends, evidence and policies. Canadian Pharmacists Journal, v. 152, n. 1, p. 45–53, 2019.

GODDERIS, L.; BOONE, A.; BAKUSIC, J. COVID-19: a new work-related disease threatening healthcare workers. Occupational Medicine, 2 maio 2020.

GT WALKER, P. et al. The Global Impact of COVID-19 and Strategies for Mitigation and Suppression. Imperial College, n. March, p. 1–19, 2020.

GUAN, W. et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European Respiratory Journal, v. 55, n. 5, p. 2000547, maio 2020.

GUO, Y. R. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status. Military Medical Research, v. 7, n. 1, p. 1–10, 2020.

HAFT, J. W. et al. Adult cardiac surgery during the COVID-19 Pandemic: A Tiered Patient Triage Guidance Statement. The Annals of thoracic surgery, n. January, 10 abr. 2020.

HARAPAN, H. et al. Coronavirus disease 2019 (COVID-19): A literature review. Journal of Infection and Public Health, v. 13, n. 5, p. 667–673, maio 2020.

HEDIMA, E. W.; ADEYEMI, M. S.; IKUNAIYE, N. Y. Community pharmacists: On the frontline of health service against COVID-19 in LMICs. Research in Social and Administrative Pharmacy, n. January, 10 abr. 2020.

HELMY, Y. A. et al. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. Journal of Clinical Medicine 2020, Vol. 9, Page 1225, v. 9, n. 4, p. 1225, 2020.

HUANG, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, v. 395, n. 10223, p. 497–506, 2020a.

HUANG, Z. et al. Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol. Biomedicine and Pharmacotherapy, v. 127, n. April, p. 110176, 2020b.

INTERNATIONAL PHARMACEUTICAL FEDERATION. Disponível em: https://www.fip.org/. Acesso em: 21 de maio de 2020.

JIN, Y. et al. Virology, epidemiology, pathogenesis, and control of covid-19. Viruses, v. 12, n. 4, p. 1–17, 2020.

KAMPF, G. et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. Journal of Hospital Infection, v. 104, n. 3, p. 246–251, 2020.

KANNAN, S. et al. COVID-19 (Novel Coronavirus 2019) - recent trends. European Review for Medical and Pharmacological Sciences, v. 24, n. 4, p. 2006–2011, 2020.

KLEPSER, M. E. et al. Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness. Journal of the American Pharmacists Association, v. 56, n. 1, p. 14–21, 2016.

KRETCHY, I. A.; ASIEDU-DANSO, M.; KRETCHY, J.-P. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries. Research in Social and Administrative Pharmacy, n. January, 10 abr. 2020.

LAI, J. et al. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA network open, v. 3, n. 3, p. e203976, 2020.

LAKE, M. A. What we know so far: COVID-19 current clinical knowledge and research. Clinical Medicine, Journal of the Royal College of Physicians of London, v. 20, n. 2, p. 124–127, 2020.

LEE, S. M. et al. Psychological impact of the 2015 MERS outbreak on hospital workers and quarantined hemodialysis patients. Comprehensive Psychiatry, v. 87, p. 123–127, 2018.

LI, H. et al. Fighting against COVID-19: Innovative strategies for clinical pharmacists. Research in Social and Administrative Pharmacy, S1551-7411(20)30328-4 abr. 2020b.

LI, J. Y. et al. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes and Infection, v. 22, n. 2, p. 80–85, mar. 2020c.

LI, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine, v. 382, n. 13, p. 1199–1207, 2020d.

LIPSITCH, M. et al. Potential biases in estimating absolute and relative case-fatality risks during outbreaks. PLoS Neglected Tropical Diseases, v. 9, n. 7, p. 1–16, 2015.

LIU, S. et al. Providing pharmacy services during the coronavirus pandemic. International Journal of Clinical Pharmacy, v. 42, n. 2, p. 299–304, 28 abr. 2020.

LIU, W.; LI, H. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxiv, n. 1, p. 31, 2020.

MACKAY, I. M.; ARDEN, K. E. MERS coronavirus: Diagnostics, epidemiology and transmission. Virology Journal, v. 12, n. 1, p. 1–21, 2015.

MAHASE, E. China coronavirus: what do we know so far? BMJ (Clinical research ed.), v. 368, n. January, p. m308, 2020.

MEYER, B.; DROSTEN, C.; MÜLLER, M. A. Serological assays for emerging coronaviruses: Challenges and pitfalls. Virus Research, v. 194, n. January, p. 175–183, dez. 2014.

ORGANIZAÇÃO MUNDIAL DA SAÚDE. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Acesso em 21 de maio de 2020.

PASCARELLA, G. et al. COVID‐19 diagnosis and management: a comprehensive review. Journal of Internal Medicine, n. March, p. joim.13091, 2020.

RABAAN, A. A. et al. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Le infezioni in medicina, v. 28, n. 2, p. 174–184, 2020.

REHM, M. et al. Protecting health-care workers: Use of a Body Covering Transparent Sheet during and after Intubation of Patients with Covid-19. Anesthesia and analgesia, p. 1, 1 maio 2020.

REMUZZI, A.; REMUZZI, G. COVID-19 and Italy: what next? The Lancet, v. 395, n. 10231, p. 1225–1228, 2020.

ROTHAN, H. A.; BYRAREDDY, S. N. The epidemeology and pathogensis of coronavirus (Covid-19) outbreak. Journal of Autoimmunity, v. 109, n. January, p. 1–4, 2020.

SCHWARTZ, D. A. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Archives of pathology & laboratory medicine, p. arpa.2020-0901-SA, 17 mar. 2020.

SHAHID, Z. et al. COVID ‐19 and Older Adults: What We Know . Journal of the American Geriatrics Society, p. 1–4, 2020.

SINGHAL, T. A Review of Coronavirus Disease-2019 (COVID-19). Indian Journal of Pediatrics, v. 87, n. 4, p. 281–286, 2020.

SONG, Z. et al. Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Research in Social and Administrative Pharmacy, n. January, p. 19–20, abr. 2020.

SPOORTHY, M. S. Mental health problems faced by healthcare workers due to the COVID-19 pandemic–A review. Asian Journal of Psychiatry, v. 51, p. 102119, jun. 2020.

STYRA, R. et al. Impact on health care workers employed in high-risk areas during the Toronto SARS outbreak. Journal of Psychosomatic Research, v. 64, n. 2, p. 177–183, 2008.

SUN, J. et al. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends in Molecular Medicine, v. 26, n. 5, p. 483–495, maio 2020.

THAO, T. T. N. et al. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature, 4 maio 2020.

TU, Y. F. et al. A review of sars-cov-2 and the ongoing clinical trials. International Journal of Molecular Sciences, v. 21, n. 7, 2020.

WANG, C. et al. A novel coronavirus outbreak of global health concern. The Lancet, v. 395, n. 10223, p. 470–473, fev. 2020.

WANG, W.; TANG, J.; WEI, F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Journal of Medical Virology, v. 92, n. 4, p. 441–447, 2020.

WEISS, M. C. et al. Use of simulated patients to assess the clinical and communication skills of community pharmacists. Pharmacy World and Science, v. 32, n. 3, p. 353–361, 2010.

WESTON, S.; FRIEMAN, M. B. COVID-19: Knowns, Unknowns, and Questions. mSphere, v. 5, n. 2, p. 18–22, 18 mar. 2020.

WU, Z.; MCGOOGAN, J. M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - Journal of the American Medical Association, v. 323, n. 13, p. 1239–1242, 2020.

YING, W.; QIAN, Y.; KUN, Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Research in Social and Administrative Pharmacy, n. January, abr. 2020.

ZHANG, H. et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv, p. 2020.01.30.927806, 2020.

ZHENG, S. et al. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Research in Social and Administrative Pharmacy, n. January, p. 19–20, mar. 2020.

ZHONG, N. et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. The Lancet, v. 362, n. 9393, p. 1353–1358, out. 2003.

ZOU, L. et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. New England Journal of Medicine, v. 382, n. 12, p. 1177–1179, 19 mar. 2020.

Artigos mais lidos pelo mesmo(s) autor(es)